Lack of B-RAF Mutations in Head and Neck Squamous Cell Carcinoma
M. Al Sheikh Ali1, Mehmet Gunduz1,2, E. Gunduz3, R. Tamamura1, L. Beder2, S. Tominaga4, T. Onoda4, N. Yamanaka2, R. Grenman5,6, K. Shimizu3, N. Nagai1, H. Nagatsuka1
1Department of Oral Pathology and Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan 2Department of Otolaryngology, Head and Neck Surgery, Wakayama Medical University, Wakayama, Japan 3Department of Molecular Genetics, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan 4Department of Otolaryngology, Head and Neck Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan 5Department of Medical Biochemistry and Molecular Biology, University of Turku and University Central Hospital, Turku, Finland 6Department of Otorhinolaryngology, Head and Neck Surgery, University of Turku and University Central Hospital, Turku, Finland
Received July 2008
Accepted September 2008
Crossref Cited-by Linking
Friedland Peter, Thomas Anitha, Naran Anupam, Amanuel Benhur, Grieu\u2010Iacopetta Fabienne, Carrello Amerigo, Harnett Gerald, Meyer Christine, Phillips Michael: Human papillomavirus and gene mutations in head and neck squamous carcinomas. ANZ Journal of Surgery2012, 82, 362. <https://doi.org/10.1111/j.1445-2197.2011.05791.x>
Sundvall Maria, Karrila Anna, Nordberg Janne, Grénman Reidar, Elenius Klaus: EGFR targeting drugs in the treatment of head and neck squamous cell carcinoma. Expert Opinion on Emerging Drugs2010, 15, 185. <https://doi.org/10.1517/14728211003716442>
Strunecká A., Hynie S., Klenerová V\u011bra: Role of Oxytocin/Oxytocin Receptor System in Regulation of Cell Growth and Neoplastic Processes. Fol. Biol.2009, 55, 159. <https://doi.org/10.14712/fb2009055050159>
